SCHEMBL4666570

SCHEMBL4666570

CCc1cccc(-c2cc(N)n(-c3c(C)cncc3C)n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 10/20 0.48
RAB9A P51151 7/20 0.48
NPC1 O15118 6/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
IDO1 P14902 1/20 0.43
MAPT P10636 7/20 0.40
STAT1 P42224 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
TP53 P04637 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 3/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4665083 0.82 MAPT (0.46) SMN1; SMN2RAB9ANPC1NFKB1NFKB2
SCHEMBL4668551 0.78 SMN1; SMN2 (0.46) SMN1; SMN2RAB9ANPC1NFKB1NFKB2
SCHEMBL4666860 0.77 ALDH1A1 (0.43) SMN1; SMN2RAB9ANPC1NFKB1NFKB2
SCHEMBL4666864 0.77 SMN1; SMN2 (0.45) SMN1; SMN2RAB9ANPC1NFKB1NFKB2
SCHEMBL4665751 0.72 HPGD (0.43) SMN1; SMN2ALDH1A1L3MBTL1MAPTMEN1
Hydrochloric Acid SCHEMBL4669539 0.72 GFER (0.41) L3MBTL1MAPTMEN1KMT2ATP53
SCHEMBL4669491 0.70 SMN1; SMN2 (0.43) SMN1; SMN2RAB9ANPC1NFKB1NFKB2
SCHEMBL25606044 0.68 KMT2A (0.56) SMN1; SMN2RAB9ANPC1NFKB1NFKB2
SCHEMBL20632573 0.67 IDO1 (0.48) SMN1; SMN2RAB9ANPC1ALDH1A1IDO1
SCHEMBL20632693 0.66 IDO1 (0.50) SMN1; SMN2RAB9AALDH1A1IDO1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed